Orient Europharma Co

Orient Europharma Co Net Margin

The Net Profit Margin of Orient Europharma Co (4120.TWO) as of Oct 17, 2026 is -12.35 %. In the previous year, Net Profit Margin was -6.47 % — a change of 90.97% (lower).

Net Margin

-12.35 %

YoY

90.97%

Last updated:

Net Profit Margin of Orient Europharma Co is 2025 -12.35 % . Net Profit Margin of Orient Europharma Co was 2024 -6.47 % . It decreases by 90.97% lower compared to the previous year.

For Orient Europharma Co, the net margin of -12.3% is down versus 2.5% a few years ago.

The Orient Europharma Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
4.48 TWD
Jan 1, 2019
4.06 TWD
Jan 1, 2020
3.70 TWD
Jan 1, 2021
2.52 TWD
Jan 1, 2022
-6.57 TWD
Jan 1, 2023
3.13 TWD
Jan 1, 2024
-6.47 TWD
Jan 1, 2025
-12.35 TWD
The Orient Europharma Co Net Margin history
YEARNet MarginYoY
-12.35 %+90.97%
-6.47 %-306.26%
3.13 %-147.71%
-6.57 %-360.63%
2.52 %-31.90%
3.70 %-8.92%
4.06 %-9.23%
4.48 %-48.98%
8.78 %-2.21%
8.98 %+97.37%
4.55 %+16.06%
3.92 %+3,506.83%
0.11 %+111.41%
0.05 %+16.54%
0.04 %-36.63%
0.07 %-2.64%
0.07 %+11.49%
0.06 %+22.85%
0.05 %-0.41%
0.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd, based in Taipei City, Taiwan, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and trades western medicine, health food, and cosmetics, with a focus on nutritious healthcare products, medical cosmetic products, and western drugs. Its product segments include infant milk powders, functional healthcare items, dermatological preparations, medical hair care, organic skincare, and pharmaceuticals for conditions such as cardiovascular diseases, cancer, and diabetes. Listed on 28 November 2002. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

Net Profit Margin of Orient Europharma Co is -12.35 % in 2025.

Net Profit Margin of Orient Europharma Co changed from -6.47 % to -12.35 %, representing a 90.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Orient Europharma Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Orient Europharma Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Orient Europharma Co